Peter Strumph

Peter Strumph

Company: Parvus Therapeutics

Job title: Chief Executive Officer


Tackling Tissue Specificity: The Translational Journey from Antigen Selection to Clinical Proof-of-Concept 2:30 pm

Selecting the antigen of choice for delivery/presentation with MHCII Highlighting data showing tissue specificity, bystander effect, disease modification, and persistence Discussing plans for clinical proof-of-concept for direct measurement of endogenously expanded Treg cellsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.